A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug ...
When it comes to alcohol use, a 2024 study of 84,000 people linked injecting Ozempic or Wegovy with a lower risk of alcoholism. Promising as that result was, it showed correlation rather than ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback